$AADI News Article - Aadi Bioscience Announces FDA Approval of its First Product FYARRO(TM) for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)
https://marketwirenews.com/news-releases/aadi...08814.html